Pyogenic granuloma
206 Pyogenic granuloma Danielle M. DeHoratius Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Pyogenic granuloma, also…
206 Pyogenic granuloma Danielle M. DeHoratius Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Pyogenic granuloma, also…
118 Keratosis pilaris and variants Nisha C. Desai and Robert A. Silverman Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E…
235 Tinea unguium Antonella Tosti and Bianca Maria Piraccini Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports…
105 Hyperhidrosis James A.A. Langtry Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Hyperhidrosis is the result…
48 Cutaneous candidiasis and chronic mucocutaneous candidiasis Caroline Halverstam and Steven R. Cohen Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5…
136 Lyme borreliosis David Banach and Gopi Patel Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports (Courtesy…
201 Pseudofolliculitis barbae Gary J. Brauner Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Pseudofolliculitis barbae (PFB)…
223 Staphylococcal scalded skin syndrome Dimitra Koch and Saleem M. Taibjee Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal…